These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 24140145)
1. The promise of riboswitches as potential antibacterial drug targets. Lünse CE; Schüller A; Mayer G Int J Med Microbiol; 2014 Jan; 304(1):79-92. PubMed ID: 24140145 [TBL] [Abstract][Full Text] [Related]
7. (Dis)similar Analogues of Riboswitch Metabolites as Antibacterial Lead Compounds. Matzner D; Mayer G J Med Chem; 2015 Apr; 58(8):3275-86. PubMed ID: 25603286 [TBL] [Abstract][Full Text] [Related]
8. Biophysical Approaches to Bacterial Gene Regulation by Riboswitches. Perez-Gonzalez C; Grondin JP; Lafontaine DA; Carlos Penedo J Adv Exp Med Biol; 2016; 915():157-91. PubMed ID: 27193543 [TBL] [Abstract][Full Text] [Related]
9. RSwitch: A Novel Bioinformatics Database on Riboswitches as Antibacterial Drug Targets. Penchovsky R; Pavlova N; Kaloudas D IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(2):804-808. PubMed ID: 32248122 [TBL] [Abstract][Full Text] [Related]
10. Riboswitches: discovery of drugs that target bacterial gene-regulatory RNAs. Deigan KE; Ferré-D'Amaré AR Acc Chem Res; 2011 Dec; 44(12):1329-38. PubMed ID: 21615107 [TBL] [Abstract][Full Text] [Related]
11. Riboswitches as therapeutic targets: promise of a new era of antibiotics. Ellinger E; Chauvier A; Romero RA; Liu Y; Ray S; Walter NG Expert Opin Ther Targets; 2023; 27(6):433-445. PubMed ID: 37364239 [TBL] [Abstract][Full Text] [Related]
12. Riboswitch-based antibacterial drug discovery using high-throughput screening methods. Penchovsky R; Stoilova CC Expert Opin Drug Discov; 2013 Jan; 8(1):65-82. PubMed ID: 23163232 [TBL] [Abstract][Full Text] [Related]
13. Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression. Lee ER; Blount KF; Breaker RR RNA Biol; 2009; 6(2):187-94. PubMed ID: 19246992 [TBL] [Abstract][Full Text] [Related]
14. 'Turning on' riboswitches to their antibacterial potential. Lea CR; Piccirilli JA Nat Chem Biol; 2007 Jan; 3(1):16-7. PubMed ID: 17173021 [No Abstract] [Full Text] [Related]
15. Monitoring ribosomal frameshifting as a platform to screen anti-riboswitch drug candidates. Yu CH; Olsthoorn RC Methods Enzymol; 2015; 550():385-93. PubMed ID: 25605396 [TBL] [Abstract][Full Text] [Related]
16. Novel riboswitch ligand analogs as selective inhibitors of guanine-related metabolic pathways. Mulhbacher J; Brouillette E; Allard M; Fortier LC; Malouin F; Lafontaine DA PLoS Pathog; 2010 Apr; 6(4):e1000865. PubMed ID: 20421948 [TBL] [Abstract][Full Text] [Related]
17. Riboswitches: From living biosensors to novel targets of antibiotics. Mehdizadeh Aghdam E; Hejazi MS; Barzegar A Gene; 2016 Nov; 592(2):244-59. PubMed ID: 27432066 [TBL] [Abstract][Full Text] [Related]
18. Design and antimicrobial action of purine analogues that bind Guanine riboswitches. Kim JN; Blount KF; Puskarz I; Lim J; Link KH; Breaker RR ACS Chem Biol; 2009 Nov; 4(11):915-27. PubMed ID: 19739679 [TBL] [Abstract][Full Text] [Related]
19. The dynamic nature of RNA as key to understanding riboswitch mechanisms. Haller A; Soulière MF; Micura R Acc Chem Res; 2011 Dec; 44(12):1339-48. PubMed ID: 21678902 [TBL] [Abstract][Full Text] [Related]